AsiaBiome is a pre-clinical stage biotech using Asia-sourced data to accelerate the discovery of microbiome based therapeutics. We create IP for a new class of drugs to license to large Pharma companies globally. We currently have programs in diabetes, IBS, autism, and oncology.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Diabetes Type 2
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):